Search the webpage

Benefits for Customers:

Choosing the right CRO for your project is critical for the success of your drug discovery and development program.

At Experimentica Ltd., we provide Scientific Excellence in Ocular ModelsSM by relying entirely on in-house expertise.

Industry-leading portfolio of in vivo imaging capabilities and functional assays;

Expert knowledge in ophthalmology and vision research;

Customizable services;

Packages for all budgets;

European and US offices.

For more information on customer benefits, do not hesitate to contact us directly.

Benefits for Customers:

Choosing the right CRO for your project is critical for the success of your drug discovery and development program.

At Experimentica Ltd., we provide Scientific Excellence in Ocular ModelsSM by relying entirely on in-house expertise.

Industry-leading portfolio of in vivo imaging capabilities and functional assays;

Expert knowledge in ophthalmology and vision research;

Customizable services;

Packages for all budgets;

European and US offices.

For more information on customer benefits, do not hesitate to contact us directly.

LATEST NEWS

Experimentica Ltd. presents strategic roadmap and announces €3,05M investment in artificial intelligence for preclinical efficacy and safety testing of ophthalmic drug candidates

News
Experimentica Ltd. revealed its strategic plan that outlines a roadmap for the development of artificial intelligence (AI)-based algorithms aimed at ... Read More

Experimentica Ltd. participates in ORBITAL, an EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award

News
Experimentica Ltd. is pleased to announce its participation as beneficiary in EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award ... Read More

A retinal organotypic model for ex vivo neuroprotection studies

News
A recently published study by Experimentica Ltd. and its collaborators from the University of Tampere, Finland, shows that when the ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!